In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SansRosa Pharmaceutical Development Inc.

Division of Nestle SA

Latest From SansRosa Pharmaceutical Development Inc.

Dermatology Start-Ups

Judging from the number of recent well-financed company launches and the size of follow-on rounds for established players, specialty dermatology hasn't lost its allure for investors. Add to that two successful 2004 IPOs--for Barrier Therapeutics Inc. and Cutera Inc.--and it's clear that aesthetic and therapeutic dermatology are still good bases for building specialty pharmaceutical businesses.
BioPharmaceutical Consumer

SansRosa Pharmaceutical Development Inc.

SansRosa, a Philadelphia-area start-up focused on dermatological conditions, is reprofiling a group of alpha agonists for use as treatments for rosacea and other disorders. The firm was founded in late 2002 and has so far raised $500,000 from Bioadvance to support its efforts.
BioPharmaceutical Business Strategies

Dermatology Start-Ups

Judging from the number of recent well-financed company launches and the size of follow-on rounds for established players, specialty dermatology hasn't lost its allure for investors. Add to that two successful 2004 IPOs--for Barrier Therapeutics Inc. and Cutera Inc.--and it's clear that aesthetic and therapeutic dermatology are still good bases for building specialty pharmaceutical businesses.
BioPharmaceutical Consumer

Start-Up Previews (3/05)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile groups: Salve for the Wound Care Market, New Drugs for Osteoporosis and Dermatology Start-Ups. Plus these Start-Ups across Health Care: Avidia Research Institute, Hansen Medical and Vitae Pharmaceuticals.
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register